Human Protein kinase C-binding protein NELL1(NELL1) ELISA kit
-
中文名稱(chēng):人蛋白激酶C結(jié)合蛋白NELL1(NELL1)酶聯(lián)免疫試劑盒
-
貨號(hào):CSB-EL015709HU
-
規(guī)格:96T/48T
-
價(jià)格:¥3600/¥2500
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:人蛋白激酶C結(jié)合蛋白NELL1(NELL1)酶聯(lián)免疫試劑盒(CSB-EL015709HU)為雙抗夾心法ELISA試劑盒,定量檢測(cè)血清、血漿、組織培養(yǎng)上清液、組織勻漿樣本中的NELL1含量。NELL1蛋白是一種新型骨誘導(dǎo)生長(zhǎng)因子,與人顱縫早閉癥相關(guān),能有效促進(jìn)骨生長(zhǎng)。其研究機(jī)制主要涉及促進(jìn)干細(xì)胞分化、誘導(dǎo)骨形成、抑制脂肪分化和炎癥反應(yīng),并與骨形態(tài)發(fā)生蛋白2等協(xié)同作用,提高骨再生安全性和有效性。試劑盒檢測(cè)范圍為31.25 pg/mL-2000 pg/mL,其多樣本兼容性支持科研人員探索NELL1在骨骼生物學(xué)、干細(xì)胞分化調(diào)控、創(chuàng)傷修復(fù)機(jī)制等領(lǐng)域的表達(dá)特征,尤其適用于骨代謝疾病模型、組織工程研究及藥物干預(yù)實(shí)驗(yàn)中的蛋白水平監(jiān)測(cè),為分子機(jī)制研究提供可靠工具。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見(jiàn)產(chǎn)品說(shuō)明書(shū)。
-
別名:FLJ45906 ELISA Kit; IDH3GL ELISA Kit; NEL like 1 (chicken) ELISA Kit; NEL like protein 1 ELISA Kit; Nel related protein 1 ELISA Kit; NEL-like 1 (chicken) ELISA Kit; NEL-like protein 1 ELISA Kit; Nel-related protein 1 ELISA Kit; NELL 1 protein short isoform ELISA Kit; Nell1 ELISA Kit; NELL1_HUMAN ELISA Kit; Neural epidermal growth factor like 1 ELISA Kit; NRP1 ELISA Kit; Protein kinase C binding protein NELL1 ELISA Kit; Protein kinase C-binding protein NELL1 ELISA Kit
-
縮寫(xiě):NELL1
-
Uniprot No.:
-
種屬:Homo sapiens (Human)
-
樣本類(lèi)型:serum, plasma, cell culture supernates, tissue homogenates
-
檢測(cè)范圍:31.25 pg/mL-2000 pg/mL
-
靈敏度:7.81 pg/mL
-
反應(yīng)時(shí)間:1-5h
-
樣本體積:50-100ul
-
檢測(cè)波長(zhǎng):450 nm
-
研究領(lǐng)域:Neuroscience
-
測(cè)定原理:quantitative
-
測(cè)定方法:Sandwich
-
精密度:
Intra-assay Precision (Precision within an assay): CV%<8% Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV%<10% Three samples of known concentration were tested in twenty assays to assess. -
線性度:
To assess the linearity of the assay, samples were spiked with high concentrations of human NELL1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. Sample Serum(n=4) 1:5 Average % 91 Range % 86-95 1:10 Average % 102 Range % 97-107 1:20 Average % 91 Range % 85-97 1:40 Average % 97 Range % 91-103 -
回收率:
The recovery of human NELL1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. Sample Type Average % Recovery Range Serum (n=5) 95 89-98 EDTA plasma (n=4) 92 88-97 -
標(biāo)準(zhǔn)曲線:
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. pg/ml OD1 OD2 Average Corrected 2000 2.907 2.987 2.947 2.768 1000 2.260 2.208 2.234 2.055 500 1.428 1.435 1.432 1.253 250 0.841 0.865 0.853 0.674 125 0.538 0.568 0.553 0.374 62.5 0.398 0.377 0.388 0.209 31.25 0.298 0.271 0.285 0.106 0 0.183 0.175 0.179 -
數(shù)據(jù)處理:
-
貨期:3-5 working days
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:Plays a role in the control of cell growth and differentiation. Promotes osteoblast cell differentiation and terminal mineralization.
-
基因功能參考文獻(xiàn):
- Results show that NELL1 methylation level was 6.8% higher in renal cell cancer (RCC) tissues associated with advanced disease of distant metastases, and shorter RFS. Analyses suggested that NELL1 DNA methylation is a promising candidate prognostic epigenetic biomarker for more detailed analyses of RCC disease. PMID: 30272321
- This work indicates that NELL-1, HMGB1, and CCN2 might enhance bone defect healing via the recruitment of endogenous cells and induction of vascularization and act via different processes than BMP2. PMID: 28463604
- NELL1 variant is associated with tobacco- and HPV-mediated oral oncogenesis. PMID: 30091681
- Results demonstrate that NELL1 is differentially expressed in fusion-positive alveolar rhabdomyosarcoma (ARMS) and in embryonal rhabdomyosarcoma (ERMS) samples, and they show that this transcriptional difference partially depends on genomic DNA methylation. The study also found that high NELL1 levels are correlated with negative RMS prognostic factors and with poor tumor outcomes. PMID: 28380437
- lipoaspirate-derived hPSCs present a novel and abundant cell source of MSCs for cartilage regeneration, and the combinatorial application of NELL-1, TGF-beta3, and BMP-6 with hPSCs may remarkably enhance and accelerate cartilage repair. PMID: 26700847
- establish the feasibility of combining NELL-1 with BMP2 to improve clinical bone regeneration and provide mechanistic insight into canonical Wnt pathway activity during NELL-1 and BMP2 osteogenesis PMID: 26772960
- Data suggest that TSPN (N-terminal thrombospondin-1-like) domain of NELL1 exhibits major heparin-binding sites which may be involved in interaction of NELL1 with cell surface heparan sulfate proteoglycans. PMID: 26627376
- NELL-1 signaling activates Wnt/beta-catenin signaling. PMID: 26082355
- We also detected lower relative expression of Nell-1 by real-time PCR. Furthermore, immunohistochemical analyses revealed that Nell-1 staining was less intense in cancer tissue relative to normal tissue and that the tumor cells had spread to the muscle PMID: 26090379
- CpG islands in the NELL1 and NELL2 promoters are hypermethylated in renal cell carcinoma.NELL1 and NELL2 protein expression is downregulated in clear cell renal carcinoma. PMID: 25726761
- NELL-1 demonstrates diffuse and reliable expression in benign but not malignant bone-forming skeletal tumors PMID: 25791475
- NELL1 overexpression greatly enhanced the osteogenic differentiation and mineral synthesis of iPSC-MSCs on RGD-grafted CPC scaffold for the first time. PMID: 25220281
- Two single-nucleotide polymorphisms of the NELL1 gene may represent a novel mechanism underlying hydrochlorothiazide-induced adverse metabolic effects (meta-analysis). PMID: 23400010
- NELL1 is able to promote the osteogenic differentiation of periodontal ligament stem cells, which may be related to the downregulation of Msx2 expression. PMID: 22767336
- Activation of the JNK pathway is necessary to mediate terminal osteogenic different-iation of Saos-2 osteosarcoma cells by rhNELL-1. PMID: 22797704
- Data indicate that LvNELL1 infection promoted the osteogenic differentiation of hADSCs, and the effect was comparable with that of LvBMP2. PMID: 23017834
- SHH and NELL-1 directed signaling produced additive effects on the pro-osteogenic and antiadipogenic differentiation of adipose derived stem cells. PMID: 22264144
- Prediction of radiographic severity in Ankolysing Spondylitis based on clinical variables can be significantly improved by including SNPs at ADRB1 (rs1801253), NELL1 (rs8176785) and MHC (rs1634747, rs9270986, rs7451962 and rs241453) genes. PMID: 22495925
- These results identify one potential mechanism of action for rhNELL-1 induced osteogenesis and highlight a fundamental difference between NELL-1 and BMP-2 signaling. PMID: 22580275
- NELL-1 may produce functional cartilage with properties similar to native cartilage. PMID: 21902605
- Results suggest that Osterix is a direct transcriptional regulator with repressive effect on NELL-1 gene expression, contributing to a delicate balance of regulatory effects on NELL-1 transcription with Runx2. PMID: 21931789
- Nell-1 is a candidate growth factor able to induce pericyte osteogenic differentiation. PMID: 21615216
- the effects of NELL-1 on osteoblastic differentiation and proliferation are partly through binding to APR3 PMID: 21723284
- The osteogenic effects of NELL1 on femoral distraction osteogenesis, was investigated. PMID: 20959151
- a potent growth factor that is highly specific to the osteochondral lineage, and has demonstrated robust induction of bone in multiple in vivo models [review] PMID: 20647499
- Data indicate that NELL1 is a ubiquitous inflammatory bowel disease susceptibility locus. PMID: 17684544
- Runx2 directly binds to the osteoblast specific binding elements 2 elements and transactivates the human NELL-1 promoter. PMID: 17042739
- Promoter hypermethylation of NELL1 is a common, tissue-specific event in human EAC, occurs early during Barrett's-associated esophageal neoplastic progression, and is a potential biomarker of poor prognosis in early-stage EAC PMID: 17452981
- findings suggest that upon binding to a specific receptor NELL1 transduces an osteogenic signal through activation of certain Tyr-kinases associated with the Ras-MAPK cascade, and finally leads to the osteogenic differentiation PMID: 18082140
- Clinical trial and genome-wide association study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator) PMID: 18519826
- Transgenic mice overexpressing Nell-1 develop craniosynostosis. PMID: 12235118
顯示更多
收起更多
-
亞細(xì)胞定位:Cytoplasm. Nucleus envelope. Secreted. Note=Colocalizes with ATRAID on the nuclear envelope and the perinuclear region.
-
數(shù)據(jù)庫(kù)鏈接:
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-